Suchergebnisse - "García Layana, Alfredo"

PubPharm (7)

1

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) : two randomised, double-masked, phase 3, non-inferiority trials

enthalten in: Lancet (London, England) | 2022

von Heier, J. | Khanani, A. | Quezada Ruiz, C. | +115

CommentIn: Lancet. 2022 Feb 19;399(10326):697-699. - PMID 35085501

2

First-line treatment algorithm and guidelines in center-involving diabetic macular edema

enthalten in: European journal of ophthalmology | 2019

von Kodjikian, L. | Bellocq, D. | Bandello, F. | +10

3

Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

enthalten in: Acta ophthalmologica | 2018

von Cobos, E. | Recalde, S. | Anter, J. | +11

4

Treatment of Exudative Age-related Macular Degeneration : Focus on Aflibercept

enthalten in: Drugs & aging | 2015

von García-Layana, A. | Figueroa, M. | Araiz, J. | +4

5

Current state of therapeutic strategies with ranibizumab in neovascular age-related macular degeneration

enthalten in: Current opinion in ophthalmology | 2015

von Gallego-Pinazo, R. | Figueroa, M. | García-Layana, A.

6

Myopic choroidal neovascularization

enthalten in: Ophthalmology | 2011

von Ruiz-Moreno, J. | López-Gálvez, M. | Donate, J. | +9

7

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion

enthalten in: European journal of ophthalmology | 2011

von Salinas-Alamán, A. | Zarranz-Ventura, J. | Caire González-Jauregui, J. | +3

1
[1]